Bone Marrow-Derived Cells Contribute to Fibrosis in the Chronically Failing Heart
Authors:
- Justin MarianiJMJustin Mariani
- Junichi SadoshimaJSJunichi Sadoshima
- David M. KayeDKDavid M. Kaye
- 1 April 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (4) , 1735-1742
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- IGF-1–Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1α/CXCR4 Signaling to Promote Myocardial RepairCirculation Research, 2008
- Stromal Cell–Derived Factor-1α Confers Protection Against Myocardial Ischemia/Reperfusion InjuryCirculation, 2007
- Mineralocorticoid receptor activation and cardiac fibrosisClinical Science, 2007
- The role of CXC chemokines in pulmonary fibrosisJournal of Clinical Investigation, 2007
- ECM remodeling in hypertensive heart diseaseJournal of Clinical Investigation, 2007
- Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in miceProceedings of the National Academy of Sciences, 2006
- The Imbalance Between Oxygen Demand and Supply as a Potential Mechanism in the Pathophysiology of Heart Failure: The Role of Microvascular Growth and AbnormalitiesMicrocirculation, 2003
- The Imbalance Between Oxygen Demand and Supply as a Potential Mechanism in the Pathophysiology of Heart Failure: The Role of Microvascular Growth and AbnormalitiesMicrocirculation, 2003
- β-blockers, angiotensin II, and ACE inhibitors in patients with heart failureThe Lancet, 2001
- Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1990